Catalyst Health Stock Hits New 52-Week High (CHSI)

NEW YORK (TheStreet) -- Catalyst Health Solutions (Nasdaq:CHSI) hit a new 52-week high Monday as it is currently trading at $64.12, above its previous 52-week high of $62.78 with 239,768 shares traded as of 10:56 a.m. ET. Average volume has been 556,300 shares over the past 30 days.

Catalyst Health has a market cap of $2.8 billion and is part of the financial sector and insurance industry. Shares are up 31.8% year to date as of the previous trading day's close.

Catalyst Health Solutions, Inc., together with its subsidiaries, operates as a pharmacy benefit management company in the United States. The company has a P/E ratio of 31.9, below the average insurance industry P/E ratio of 33.9 and above the S&P 500 P/E ratio of 16.7.

• Practice your CHSI trading strategies and win cash in our stock game.

TheStreet Ratings rates Catalyst Health as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Catalyst Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

For more information on Catalyst Health Solutions Inc. click any of the following:

• Catalyst Health Solutions Inc. Stock Price

• Catalyst Health Solutions Inc. Analyst Ratings

• Catalyst Health Solutions Inc. Key Stats & Profile

• Catalyst Health Solutions Inc. Earnings

• Catalyst Health Solutions Inc. Ratio Comparison

• Catalyst Health Solutions Inc. Growth Rates

• Catalyst Health Solutions Inc. Balance Sheet

• Catalyst Health Solutions Inc. Cash Flow

• Catalyst Health Solutions Inc. Income Statement